Back to Browse Journals » Neurobehavioral HIV Medicine » Volume 3

Stress management interventions for HIV-infected individuals: review of recent intervention approaches and directions for future research

Authors Brown JL, Vanable PA

Published Date November 2011 Volume 2011:3 Pages 95—106

DOI http://dx.doi.org/10.2147/NBHIV.S17829

Published 8 November 2011

Jennifer L Brown1,2, Peter A Vanable3
1Department of Behavioral Sciences and Health Education, 2Center for AIDS Research, Emory University, Atlanta, GA, USA; 3Department of Psychology, Syracuse University, Syracuse, NY, USA

Abstract: To promote psychological wellbeing and adaptive coping among people living with human immunodeficiency virus/acquired immune deficiency syndrome (PLWHA), a number of stress management interventions have been designed and evaluated. This paper reviews recent stress management intervention approaches designed to improve the coping skills of PLWHA and reduce psychological distress. First, a summary of findings from previous narrative reviews and meta-analyses of the stress management intervention literature for PLWHA is provided. Next, recent stress management interventions for PLWHA that fall into one of four categories are reviewed: (a) interventions to improve coping and modify other health behaviors (ie, highly active antiretroviral medication adherence, sexual behaviors), (b) meditation, mindfulness, and relaxation-based stress management approaches, (c) computer-delivered interventions, and (d) interventions that target specific populations including older individuals, individuals with childhood sexual abuse histories, and women. A critique of recent stress management interventions for PLWHA is provided as well as directions for future research.

Keywords: stress management intervention, stress, coping, cognitive behavioral stress management, review, HIV, HIV-positive, HIV-infected, AIDS

Download Article [PDF] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Readers of this article also read:

Pharmacokinetics and pharmacodynamics of acetylsalicylic acid after intravenous and oral administration to healthy volunteers

Nagelschmitz J, Blunck M, Kraetzschmar J, Ludwig M, Wensing G, Hohlfeld T

Clinical Pharmacology: Advances and Applications 2014, 6:51-59

Published Date: 19 March 2014

Population pharmacokinetics of olprinone in healthy male volunteers

Kunisawa T, Kasai H, Suda M, Yoshimura M, Sugawara A, Izumi Y, Iida T, Kurosawa A, Iwasaki H

Clinical Pharmacology: Advances and Applications 2014, 6:43-50

Published Date: 4 March 2014

Consequences of the 118A>G polymorphism in the OPRM1 gene: translation from bench to bedside?

Mura E, Govoni S, Racchi M, Carossa V, Ranzani GN, Allegri M, van Schaik RHN

Journal of Pain Research 2013, 6:331-353

Published Date: 1 May 2013

Co-nanoencapsulation of magnetic nanoparticles and selol for breast tumor treatment: in vitro evaluation of cytotoxicity and magnetohyperthermia efficacy

Estevanato LC, Da Silva JR, Falqueiro AM, Mosiniewicz-Szablewska E, Suchocki P, Tedesco AC, Morais PC, Lacava ZG

International Journal of Nanomedicine 2012, 7:5287-5299

Published Date: 5 October 2012

Quality of life of people living with HIV and AIDS and antiretroviral therapy

Oguntibeju OO

HIV/AIDS - Research and Palliative Care 2012, 4:117-124

Published Date: 6 August 2012

Detemir as a once-daily basal insulin in type 2 diabetes

Nelson SE

Clinical Pharmacology: Advances and Applications 2011, 3:27-37

Published Date: 18 August 2011